Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.

Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2019 04; 12(4):e007133.

View in: PubMed

subject areas

Aged
Anemia
Biomarkers
Coronary Artery Disease
Drug Administration Schedule
Drug Therapy, Combination
Female
Hemoglobins
Hemorrhage
Humans
Male
Medication Adherence
Middle Aged
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Prospective Studies
Registries
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome

authors with profiles

Usman Baber